vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Ralliant Corp (RAL). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.0B vs $529.1M, roughly 1.9× Ralliant Corp). Ralliant Corp runs the higher net margin — 7.5% vs -1.1%, a 8.6% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs -0.5%). Ralliant Corp produced more free cash flow last quarter ($126.6M vs $-55.4M).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

ALHC vs RAL — Head-to-Head

Bigger by revenue
ALHC
ALHC
1.9× larger
ALHC
$1.0B
$529.1M
RAL
Growing faster (revenue YoY)
ALHC
ALHC
+44.9% gap
ALHC
44.4%
-0.5%
RAL
Higher net margin
RAL
RAL
8.6% more per $
RAL
7.5%
-1.1%
ALHC
More free cash flow
RAL
RAL
$182.0M more FCF
RAL
$126.6M
$-55.4M
ALHC

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ALHC
ALHC
RAL
RAL
Revenue
$1.0B
$529.1M
Net Profit
$-11.0M
$39.9M
Gross Margin
50.8%
Operating Margin
-1.0%
9.8%
Net Margin
-1.1%
7.5%
Revenue YoY
44.4%
-0.5%
Net Profit YoY
64.6%
-56.1%
EPS (diluted)
$-0.04
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
RAL
RAL
Q4 25
$1.0B
Q3 25
$993.7M
$529.1M
Q2 25
$1.0B
$503.3M
Q1 25
$926.9M
Q4 24
$701.2M
Q3 24
$692.4M
$531.7M
Q2 24
$681.3M
$533.7M
Q1 24
$628.6M
Net Profit
ALHC
ALHC
RAL
RAL
Q4 25
$-11.0M
Q3 25
$3.7M
$39.9M
Q2 25
$15.7M
$47.6M
Q1 25
$-9.1M
Q4 24
$-31.1M
Q3 24
$-26.4M
$90.9M
Q2 24
$-24.0M
$64.8M
Q1 24
$-46.5M
Gross Margin
ALHC
ALHC
RAL
RAL
Q4 25
Q3 25
50.8%
Q2 25
49.3%
Q1 25
Q4 24
Q3 24
52.6%
Q2 24
51.5%
Q1 24
Operating Margin
ALHC
ALHC
RAL
RAL
Q4 25
-1.0%
Q3 25
0.8%
9.8%
Q2 25
2.2%
11.7%
Q1 25
-0.6%
Q4 24
-3.2%
Q3 24
-2.8%
20.9%
Q2 24
-2.7%
19.7%
Q1 24
-6.5%
Net Margin
ALHC
ALHC
RAL
RAL
Q4 25
-1.1%
Q3 25
0.4%
7.5%
Q2 25
1.5%
9.5%
Q1 25
-1.0%
Q4 24
-4.4%
Q3 24
-3.8%
17.1%
Q2 24
-3.5%
12.1%
Q1 24
-7.4%
EPS (diluted)
ALHC
ALHC
RAL
RAL
Q4 25
$-0.04
Q3 25
$0.02
$0.35
Q2 25
$0.07
$0.42
Q1 25
$-0.05
Q4 24
$-0.15
Q3 24
$-0.14
$0.81
Q2 24
$-0.13
$0.57
Q1 24
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
RAL
RAL
Cash + ST InvestmentsLiquidity on hand
$604.2M
$264.2M
Total DebtLower is stronger
$323.2M
$1.1B
Stockholders' EquityBook value
$179.3M
$3.0B
Total Assets
$1.1B
$5.3B
Debt / EquityLower = less leverage
1.80×
0.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
RAL
RAL
Q4 25
$604.2M
Q3 25
$644.1M
$264.2M
Q2 25
$503.8M
$198.6M
Q1 25
$479.5M
Q4 24
$470.6M
Q3 24
$381.0M
Q2 24
$363.7M
Q1 24
$301.7M
Total Debt
ALHC
ALHC
RAL
RAL
Q4 25
$323.2M
Q3 25
$322.7M
$1.1B
Q2 25
$322.3M
$1.1B
Q1 25
$321.9M
Q4 24
$321.4M
Q3 24
$212.0M
Q2 24
$211.7M
Q1 24
$162.0M
Stockholders' Equity
ALHC
ALHC
RAL
RAL
Q4 25
$179.3M
Q3 25
$161.9M
$3.0B
Q2 25
$141.0M
$3.0B
Q1 25
$108.1M
Q4 24
$99.9M
Q3 24
$114.5M
$4.0B
Q2 24
$123.7M
$4.0B
Q1 24
$130.9M
Total Assets
ALHC
ALHC
RAL
RAL
Q4 25
$1.1B
Q3 25
$1.1B
$5.3B
Q2 25
$1.0B
$5.2B
Q1 25
$895.6M
Q4 24
$782.1M
Q3 24
$692.3M
Q2 24
$716.3M
Q1 24
$633.2M
Debt / Equity
ALHC
ALHC
RAL
RAL
Q4 25
1.80×
Q3 25
1.99×
0.39×
Q2 25
2.29×
0.38×
Q1 25
2.98×
Q4 24
3.22×
Q3 24
1.85×
Q2 24
1.71×
Q1 24
1.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
RAL
RAL
Operating Cash FlowLast quarter
$-50.4M
$138.6M
Free Cash FlowOCF − Capex
$-55.4M
$126.6M
FCF MarginFCF / Revenue
-5.5%
23.9%
Capex IntensityCapex / Revenue
0.5%
2.3%
Cash ConversionOCF / Net Profit
3.47×
TTM Free Cash FlowTrailing 4 quarters
$113.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
RAL
RAL
Q4 25
$-50.4M
Q3 25
$144.6M
$138.6M
Q2 25
$29.1M
Q1 25
$16.6M
Q4 24
$-8.7M
Q3 24
$26.2M
Q2 24
$23.5M
Q1 24
$-6.2M
Free Cash Flow
ALHC
ALHC
RAL
RAL
Q4 25
$-55.4M
Q3 25
$139.1M
$126.6M
Q2 25
$21.1M
Q1 25
$8.4M
Q4 24
$-18.0M
Q3 24
$16.9M
Q2 24
$11.8M
Q1 24
$-17.4M
FCF Margin
ALHC
ALHC
RAL
RAL
Q4 25
-5.5%
Q3 25
14.0%
23.9%
Q2 25
2.1%
Q1 25
0.9%
Q4 24
-2.6%
Q3 24
2.4%
Q2 24
1.7%
Q1 24
-2.8%
Capex Intensity
ALHC
ALHC
RAL
RAL
Q4 25
0.5%
Q3 25
0.6%
2.3%
Q2 25
0.8%
Q1 25
0.9%
Q4 24
1.3%
Q3 24
1.3%
Q2 24
1.7%
Q1 24
1.8%
Cash Conversion
ALHC
ALHC
RAL
RAL
Q4 25
Q3 25
38.77×
3.47×
Q2 25
1.86×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALHC
ALHC

Segment breakdown not available.

RAL
RAL

Industrial Manufacturing$111.1M21%
Defense And Space$93.6M18%
Diversified Electronics$91.0M17%
Test And Measurement$76.8M15%
Communications$60.7M11%
Semiconductors$51.4M10%
Other Direct End Markets$44.4M8%

Related Comparisons